50% off all subscriptions! ... left. Order NowOrder Now

Weaker Stock
Today GLUE ranks #10405 as sell candidate. Get a Free Stock at Robinhood
Stronger Stock

Monte Rosa Therapeutics, Inc. Stock Forecast NASDAQ:GLUE

$20.55 (14.23%)

Volume: 112k

Closed: Nov 26, 2021

Hollow Logo Score: -3.125

Monte Rosa Therapeutics, Inc. Stock Forecast

$20.55 (14.23%)

Volume: 112k

Closed: Nov 26, 2021

Score Hollow Logo -3.125
Which way will GLUE go? Request

GLUE Stock Risk

This stock may move very much during the day (volatility) and with a very large prediction interval from the Bollinger Band this stock is considered to be "very high risk". During the last day, the stock moved $3.22 between high and low, or 18.26%. For the last week, the stock has had a daily average volatility of 10.88%.

Our recommended stop-loss: We hold a sell evaluation for this stock. No stop-loss set.

Overall risk:

Very Low Low Medium High Very High

* StockInvest.us uses dynamically calculated RSI max/min levels to determine when stock is oversold or overbought based on historical behavior.
RSImin/max Values: [ 15 - 80 ] RSI14 is 36 and the stock is currently not being overbought or oversold

Big movements in Monte Rosa Therapeutics, Inc. stock price on Friday moving 18.26% between high and low
(Updated on Nov 26, 2021)


Sell candidate since 2021-11-15 Loss -10.65%

The Monte Rosa Therapeutics, Inc. stock price gained 14.23% on the last trading day (Friday, 26th Nov 2021), rising from $17.99 to $20.55. During the day the stock fluctuated 18.26% from a day low at $17.63 to a day high of $20.85. The price has fallen in 6 of the last 10 days and is down by -16.53% for this period. Volume fell on the last day by -32 thousand shares and in total, 112 thousand shares were bought and sold for approximately $2.30 million. You should take into consideration that falling volume on higher prices causes divergence and may be an early warning about possible changes over the next couple of days.

The stock lies the upper part of a very wide and falling trend in the short term, and this may normally pose a very good selling opportunity for the short-term trader as reaction back towards the lower part of the trend can be expected. A break up at the top trend line at $22.35 will firstly indicate a slower falling rate, but may be the first sign of a trend shift. Given the current short-term trend, the stock is expected to fall -40.33% during the next 3 months and, with a 90% probability hold a price between $5.75 and $13.34 at the end of this 3-month period. Do note, that if the stock price manages to stay at current levels or higher, our prediction target will start to change positively over the next few days as the conditions for the current predictions will be broken.

Signals & Forecast

Volume fell during the last trading day despite gaining prices. This causes a divergence between volume and price and it may be an early warning. The stock should be watched closely. Some negative signals were issued as well, and these may have some influence on the near short-term development. The Monte Rosa Therapeutics, Inc. stock holds a buy signal from the short-term moving average; at the same time, however, the long-term average holds a general sell signal. Since the longterm average is above the short-term average there is a general sell signal in the stock giving a more negative forecast for the stock. On further gains, the stock will meet resistance from the long-term moving average at $22.76. On a fall, the stock will find some support from the short-term average at $19.93. A break-up through the long-term average will give another buy signal, while a fall below the short-term average will add another sell signal and strengthen the general signal. A sell signal was issued from a pivot top point on Thursday, October 28, 2021, and so far it has fallen -24.31%. Further fall is indicated until a new bottom pivot has been found. Furthermore, there is currently a sell signal from the 3 month Moving Average Convergence Divergence (MACD).

Support, Risk & Stop-loss

Monte Rosa Therapeutics, Inc. finds support from accumulated volume at $20.07 and this level may hold a buying opportunity as an upwards reaction can be expected when the support is being tested.

This stock may move very much during the day (volatility) and with a very large prediction interval from the Bollinger Band this stock is considered to be "very high risk". During the last day, the stock moved $3.22 between high and low, or 18.26%. For the last week, the stock has had a daily average volatility of 10.88%.

Our recommended stop-loss: We hold an negative evaluation for this stock. No stop-loss is set.

Is Monte Rosa Therapeutics, Inc. stock A Buy?

Monte Rosa Therapeutics, Inc. holds several negative signals and is within a very wide and falling trend, so we believe it will still perform weakly in the next couple of days or weeks. We therefore hold a negative evaluation of this stock. We have upgraded our analysis conclusion for this stock since the last evaluation from a Strong Sell to a Sell candidate.

Current score: -3.125

Predicted Opening Price for Monte Rosa Therapeutics, Inc. of Monday, November 29, 2021

The predicted opening price is based on yesterday's movements between high, low, and the closing price.

Fair opening price November 29, 2021 Current price
$19.68 $20.55 (Overvalued)
Sell Candidate Upgraded

Remember To Visit Our YouTube Channel

Analyst Ratings

On Nov 17, 2021 "Berenberg Bank" gave "" rating for GLUE. The price target was set to $21.90+0.0%.

Volatility and Risk
Daily Average Volatility: 10.88 %
Overall Risk: Very High High Medium Low Very Low
Volatility
10.88 %
Daily Average Volatility
Overall Risk

Very High
High
Medium
Low
Very Low

Support & Resistance

Resistance: $21.20
Price: $20.55
Support: $20.07

GLUE Insider Trading Show all Trades

INSIDER POWER

0.906

Last 76 transactions
Buy: 95 569 430 | Sell: 105 475 975 (Shares)
Date Action Amount Person Type
Jun 28, 2021 Buy 600 000 Cormorant Asset Management, Lp Common Stock
Jun 28, 2021 Buy 2 602 200 Cormorant Asset Management, Lp Common Stock
Jun 28, 2021 Buy 2 124 343 Cormorant Asset Management, Lp Series B Convertible Preferred Stock
Jun 28, 2021 Buy 2 715 968 Landsman Liza Common Stock
Jun 28, 2021 Buy 3 257 328 Landsman Liza Common Stock
Show all Insider Trades
INSIDER POWER

0.906

Last 76 transactions
Buy: 95 569 430 | Sell: 105 475 975 (Shares)

Fibonacci Support & Resistance Levels

Level Price Change
Resistance 22.90 11.42 %
21.67 5.43 %
20.91 1.74 %
Current price: 20.55
Support 18.45 -10.24 %
17.69 -13.93 %
16.46 -19.92 %

Accumulated Volume Support & Resistance Levels

Level Price Chg %
Resistance 24.70 20.19 %
23.30 13.38 %
21.20 3.16 %
Current price 20.55
Support 20.07 -2.34%
19.64 -4.43%
17.99 -12.46%

Click to get the best stock tips daily for free!

Golden Star Signal

This unique signal uses moving averages and adds special requirements that convert the very good Golden Cross into a Golden Star.

This signal is rare and, in most cases, gives substantial returns. From 10 000+ stocks usually only a few will trigger a Golden Star Signal per day!

Get access to Golden Star list now!

StockInvest.usJoin 100 000+ Happy Subscribers

Don't miss out on the runners!

Get The StockInvest.Us Newsletter

StockInvest.usStock Podcast

Top Fintech Company

StockInvest.us featured in The Global Fintech Index 2020 as the top Fintech company of the country.

Full report by FINDEXABLE

ROCKIT